Overview

Tech Summary

Promoter Holding

Posts

GLENMARK

301234567898012345678910123456789.2012345678950123456789
-17.60 (-4.41%)
The current prices are delayed.Login/Sign Up to see live prices.
Previous Close: 398.85
1D
5D
1M
3M
1Y
5Y
Today's low
379.75
Today's high
405.75
52 week low
348.5
52 week high
542.7
Volume
1203872
About
Tech Summary
DMA(12)
₹427.31
DMA(50)
₹407.29
DMA(100)
₹394.02
DMA(200)
₹409.9
Fund Summary
Market Cap
₹10758.88 Cr.
Enterprise Value
₹14307.15 Cr.
No. of Shares
28.22
P/E
11.42
RoE
14.81
Debt/Equity
0.67
Valuations
PE Chart
5.05.56.06.5
PB Chart
1.101.201.301.401.50
Promoter Holdings
Public : 18.27%
FII : 24.12%
DII : 10.96%
Promoter : 46.65%
Others : 0%
Charts
Debt/Equity
0.700.750.800.850.90
Mar, 2018Mar, 2019Mar, 2020Mar, 2021
ROE vs ROCE
12.013.014.015.016.017.018.0
Mar, 2018Mar, 2019Mar, 2020Mar, 2021
ROE
ROCE
Revenue vs Profitability (1000Cr.)
24681012
Mar, 2018Mar, 2019Mar, 2020Mar, 2021
Revenue
Profit
Margins(%)
8101214161820
Mar, 2018Mar, 2019Mar, 2020Mar, 2021
Net Margin
Gross Margin
About
Hero Img
Create your account on Frontpage
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
Price Target Potential
Brokerage
Motilal Oswal
ICICIdirect.com
Target
520
550
Potential
21.64%
12.96%
Stock Sentiments
80% Bullish
20% Bearish
20 live trades of Rs. 355,915.5
S
shareefcp
 
Reputation: 0 • 
Just now
GLENMARK
50 Qty (S) Validity Over₹45
Shritam999
 
Reputation: 0 • 
Today 4:41 PM
GLENMARK FEB23 380 PE
145000 Qty (S) Exited₹5,80,000
Posts by FrontPage Users
NewsBot-display-image
Reputation: 29,687  •  Just now
Glenmark Life Sciences Q3 Results: Profit rises 1% on API strength
Glenmark Life Sciences Q3 Results: Profit rises 1% on API strength
Glenmark Life Sciences, which was spun off from Glenmark Pharmaceuticals in 2019 to focus on the API business, posted revenue from operations of 5.41 billion rupees, up 3.5% from the previous year.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Jan 23 5:18 PM
Glenmark introduces medication to prevent chemotherapy-induced nausea
Glenmark introduces medication to prevent chemotherapy-induced nausea
The company has introduced IV injection formulation Akynzeo IV in a fixed dose combination of fosnetupitant (235 mg) and palonosetron (0.25 mg) and is available as a ready-to-dilute IV injection, the Mumbai-based drug maker said in a statement.
Moneycontrol
Like
Comment
Share
Add a comment
B
Reputation: 140  •  Jan 21 2:06 AM
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Jan 19 3:38 PM
MC Analysis I Why India’s cardiology pharma market is expecting a major disruption this year
MC Analysis I Why India’s cardiology pharma market is expecting a major disruption this year
With a blockbuster heart failure drug Vymada going off-patent this month, its much cheaper generic versions by a number of drug makers are set to hit the market in India and several other countries. 
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Jan 18 1:26 AM
India's Eris Lifesciences to buy some dermatology brands from Glenmark Pharma
India's Eris Lifesciences to buy some dermatology brands from Glenmark Pharma
The deal for the portfolio that has an annual revenue base of 850 million rupees, will be financed through borrowings, and the transaction is expected to achieve financial closure very soon, Eris said
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Jan 17 7:53 PM
Glenmark launches drug to treat heart failure
Glenmark launches drug to treat heart failure
The prescription drug has been launched under brand 'Sacu V' and is priced at Rs 19 per tablet for a dose of 50mg (sacubitril 24mg + valsartan 26mg), Rs 35 per tablet for a dose of 100mg (sacubitril 49mg + valsartan 51mg), and Rs 45 per tablet for a dose of 200mg (sacubitril 97mg + valsartan 103 mg), Glenmark said in a regulatory filing.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Jan 10 7:33 PM
Glenmark launches generic version of diuretic with $16.5-million market
Glenmark launches generic version of diuretic with $16.5-million market
Glenmark Pharmaceuticals will launch single-dose and multi-dose vials of Bumetanide injection USP, the company has said
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Jan 10 4:38 PM
Glenmark Pharmaceuticals launches generic version of diuretic Bumetanide injection
Glenmark Pharmaceuticals launches generic version of diuretic Bumetanide injection
In a statement the company said Glenmark Pharmaceuticals Inc., USA (Glenmark) launched Bumetanide Injection of strengths of 1 mg/4 mL (0.25 mg/mL) single-dose vials and 2.5 mg/10 mL (0.25 mg/mL) multi-dose vials.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Dec 23, 2022 11:41 AM
Defensive sectors in focus again on rising Covid cases
Defensive sectors in focus again on rising Covid cases
The recent resurgence in Covid infections - against a backdrop of tightening monetary policies and hawkish commentaries by global central banks that could potentially trigger a global recession has dragged India's benchmark indices down by nearly 5% after hitting their all-time highs on December 1.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Dec 22, 2022 1:01 PM
Stocks in the news: Sula Vineyards, RIL, Adani Enterprises, Bandhan Bank and Adani Power
Stocks in the news: Sula Vineyards, RIL, Adani Enterprises, Bandhan Bank and Adani Power
Sula Vineyards, India's largest wine producer, will make its debut on the bourses on Thursday. The company had raised a little more than Rs 960 crore between December 12-14 and sold its shares Rs 357 apeice.
The Economic Times
Like
Comment
Share
Add a comment
Option Master Intraday-display-image
Reputation: 61,103  •  Dec 22, 2022 2:46 AM


💎Glenmark Breakout for Tomorrow:

🔰Glenmark tested 445 level 3 times in past months now it has come again today so there will be big possibility of Glenmark to cross and give breakout above 445.

🔰Glenmark average volume per day 600K-1M but today we saw volume of 6......read more
Chartbusters - chart - 19734711
19 Likes
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Dec 21, 2022 7:16 PM
Glenmark Pharmaceuticals rises 5% on launching first 3-drug FDC for type-2 diabetes in India
Glenmark Pharmaceuticals rises 5% on launching first 3-drug FDC for type-2 diabetes in India
“This FDC has been launched under the brand name Zita®-PioMet,” the company said in a BSE filing. “This offers patients with Type 2 diabetes the convenience of once-daily dosing to improve their glycemic control and achieve the targeted HbA1c within 24 weeks,” it added.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Dec 21, 2022 4:13 PM
Glenmark gains 2% after launching Zita Piomet for type 2 diabetes
Glenmark gains 2% after launching Zita Piomet for type 2 diabetes
The drug contains Teneligliptin (20 mg) + Pioglitazone (15 mg) + Metformin (500mg/1000mg) in a sustained release (SR) formulation and help to improve glycemic control among adults with High HbA1ci and high insulin resistance.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Dec 21, 2022 3:58 PM
Glenmark Pharma launches combination drug for diabetic patients
Glenmark Pharma launches combination drug for diabetic patients
This fixed-dose combination offers patients with Type 2 diabetes the convenience of once daily dosing to improve their glycemic control. It is priced at Rs 14.90 per day, thereby reducing the daily cost of therapy by 40 per cent, making it more affordable to the masses, the company said in a statement.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Dec 15, 2022 12:56 PM
Stocks in the news: SBI, Wipro, Tata Motors, IRCTC, Power Grid and multiplexes
Stocks in the news: SBI, Wipro, Tata Motors, IRCTC, Power Grid and multiplexes
State Bank of India said its board has approved Rs 10,000 crore capital raising plan through Tier I bonds. The fund raising through Additional Tier 1 capital up to an amount of Rs 10,000 crore is subject to approval from the government.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Dec 14, 2022 11:03 PM
Glenmark Pharma inks pact with JB Chemicals to divest Razel brand in India, Nepal for Rs 314 crore
Glenmark Pharma inks pact with JB Chemicals to divest Razel brand in India, Nepal for Rs 314 crore
The transaction is expected to be closed by the end of this calendar year, Glenmark Pharma said, adding that the divestment is in line with the company's strategy to focus on "other sub‐categories of the cardio‐vascular segment".
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Dec 12, 2022 12:36 PM
Stocks in the news: Uniparts, Airtel, NTPC, Vodafone Idea, Marico and Glenmark
Stocks in the news: Uniparts, Airtel, NTPC, Vodafone Idea, Marico and Glenmark
Uniparts India will be listed at bourses on Monday. Its Rs 835.6 crore IPO was open was open between November 30 and December 2, sold in the range of Rs 548-577. It issue was overall subscribed more than 25.3 times.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Dec 12, 2022 12:23 PM
Hot Stocks | Here is why you should bet on Macrotech Developers, Advanced Enzyme Technologies, Glenmark Pharma in short term
Hot Stocks | Here is why you should bet on Macrotech Developers, Advanced Enzyme Technologies, Glenmark Pharma in short term
On the indicator front, daily MACD displays bullish divergence on the histogram and its respective lines. Daily DMI’s are positive and advancing its structure further adding strength to Advanced Enzyme Technologies.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Dec 11, 2022 7:46 PM
ETMarkets Smart Talk | Overlooking IT stocks as investment bet for now: Sumeet Bagadia
ETMarkets Smart Talk | Overlooking IT stocks as investment bet for now: Sumeet Bagadia
Nifty had a phenomenal run in the month of October and November and has potentially delivered over 10 percent return in just two months. There were lots of stirs and juggle globally in the past couple of weeks, but the market ignored the noise and deliberately moved higher.
The Economic Times
Like
Comment
Share
Add a comment
Vikas Prajapati-display-image
Reputation: 1,842  •  Dec 10, 2022 1:15 PM

#GLENMARK charts looks promising to go above 480
Buy on dip and maintain SL 400 closing bases.
Chartbusters - chart - 18463019
Like
Comment
Share
Add a comment
Trading Addict-display-image
Reputation: 26,233  •  Dec 3, 2022 5:46 AM

GLENMARK FOR SWING
BUY at 435
Target 485, 540
Stoploss 398
7 Likes
3 Comments
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Nov 30, 2022 9:26 PM
Buy Glenmark Pharmaceuticals, target price Rs 580:  Nomura, India
Buy Glenmark Pharmaceuticals, target price Rs 580: Nomura, India
Glenmark Pharmaceuticals, incorporated in the year 1977, is a Mid Cap company (having a market cap of Rs 12152.98 Crore) operating in Pharmaceuticals sector.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Nov 25, 2022 9:08 PM
Neutral Glenmark Pharma; target of Rs 420: Motilal Oswal
Neutral Glenmark Pharma; target of Rs 420: Motilal Oswal
Motilal Oswal recommended Neutral rating on Glenmark Pharma with a target price of Rs 420 in its research report dated November 14, 2022.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Nov 24, 2022 2:48 PM
US drug regulator issues warning letter to Glenmark's Goa unit
US drug regulator issues warning letter to Glenmark's Goa unit
In October, the company's Baddi unit was placed under an import alert by the USFDA. It had been issued a warning letter by the drug regulator in October 2019.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Nov 22, 2022 5:13 PM
Hold Glenmark Pharmaceuticals; target of Rs 470: ICICI Direct
Hold Glenmark Pharmaceuticals; target of Rs 470: ICICI Direct
ICICI Direct recommended hold rating on Glenmark Pharmaceuticals with a target price of Rs 470 in its research report dated November 21, 2022.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Nov 22, 2022 3:33 PM
Glenmark Pharma reaches settlement agreement with Pfizer for Axitinib Tablets
Glenmark Pharma reaches settlement agreement with Pfizer for Axitinib Tablets
According to sales data for the 12‐month period ending September 2022, the Inlyta Tablets, 1 mg and 5 mg, achieved annual sales of approximately $644.5 million
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Nov 21, 2022 9:03 PM
Accumulate Glenmark Pharmaceuticals; target of Rs 460: Prabhudas Lilladher
Accumulate Glenmark Pharmaceuticals; target of Rs 460: Prabhudas Lilladher
Prabhudas Lilladher recommended accumulate rating on Glenmark Pharmaceuticals with a target price of Rs 460 in its research report dated November 19, 2022.
Moneycontrol
1 Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Nov 21, 2022 4:08 PM
Top 10 trading ideas for next 3-4 weeks in a market moving largely sideways
Top 10 trading ideas for next 3-4 weeks in a market moving largely sideways
Breaching either side of 18,200-18,450 range can give some kind of direction to the market in the coming days, but having a monthly expiry and FOMC minutes scheduled this week, volatility and consolidation is at the top before any kind of big move on either side of range
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Nov 20, 2022 10:36 PM
Ahead of Market: 10 things that will decide D-Street action on Monday
Ahead of Market: 10 things that will decide D-Street action on Monday
Vinod Nair, Head of Research at Geojit Financial Services, "Domestic market is now focusing on global trends for future direction due to lack of domestic triggers. Negative vibes in the developed market and aggressive comments from Fed officials have shaken the ongoing optimistic trend across the globe. Despite a late attempt of recovery, the domestic market largely traded with a negative shade, in all sectors except PSU banks."
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Nov 18, 2022 9:23 PM
Neutral Glenmark Pharma; target of Rs 420 : Motilal Oswal
Neutral Glenmark Pharma; target of Rs 420 : Motilal Oswal
Motilal Oswal recommended Neutral rating on Glenmark Pharma with a target price of Rs 420 in its research report dated November 17, 2022.
Moneycontrol
Like
Comment
Share
Add a comment
URFinMaster-display-image
Reputation: 14,652  •  Nov 14, 2022 3:56 PM
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Nov 14, 2022 12:41 PM
Stocks in the news: LIC, Godrej Properties, ONGC, Fortis, Bharat Dynamics and ZEEL
Stocks in the news: LIC, Godrej Properties, ONGC, Fortis, Bharat Dynamics and ZEEL
ONGC, Grasim, IRCTC, Bharat Forge, Biocon, Abbott India, Balkrishna Industries, NMDC, Aarti Industries, AIA Engineering, GMR Infra, Godrej Industries and Radico Khaitan are among the companies that will announce their results for September 2022 quarter today.
The Economic Times
Like
Comment
Share
Add a comment
StockTradeX-display-image
Reputation: 4,434  •  Nov 12, 2022 2:12 PM
3 Likes
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Nov 12, 2022 3:01 AM
Glenmark Q2 Results: Net profit rises 1.4% YoY to Rs 278 crore
Glenmark Q2 Results: Net profit rises 1.4% YoY to Rs 278 crore
Revenues rose 7.2% YoY to Rs 3,375 crore during Q2FY23 as against Rs 3,147 crore in Q2FY22
The Economic Times
Like
Comment
Share
Add a comment
Index Option-display-image
Reputation: 6,314  •  Nov 8, 2022 8:06 PM
1 Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Nov 2, 2022 6:28 PM
Glenmark gets USFDA nod for generic medication
Glenmark gets USFDA nod for generic medication
The company has received final approval from the US Food and Drug Administration (USFDA) for the product which is a generic version of Horizon Therapeutics' Buphenyl, the Mumbai-based drug maker said in a statement.
Moneycontrol
Like
Comment
Share
Add a comment
Profit Picks-display-image
Reputation: 676  •  Nov 1, 2022 10:30 PM

Breakout in Glenmark pharma
Green hammer candle over 50 days moving average
RSI positive and raising, macd giving buy singnal
With good volumes
Chartbusters - chart - 15091558
Like
Comment
Share
Add a comment
Ashutosh Trading YouTube-display-image
Reputation: 2,081  •  Nov 1, 2022 4:58 PM

glenmark phrama is making channel. Glenmark Pharma is making canal as on daily timeframe as i already mark in the chart. we can plan a upside swing trade if it breaks upside and then retest it.

buy 430
stoploss 390
target 480


or kisi stock ka analysis chahiye to com......read more
Chartbusters - chart - 15037864
2 Likes
12 Comments
Share
Add a comment
StockTradeX-display-image
Reputation: 4,434  •  Nov 1, 2022 2:54 PM
Like
5 Comments
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Nov 1, 2022 1:06 PM
Stocks in the news: Tata Steel, Sun Pharma, Airtel, Axis Bank, L&T and Glenmark
Stocks in the news: Tata Steel, Sun Pharma, Airtel, Axis Bank, L&T and Glenmark
Sun Pharma, Adani Ports, TechM, UPL, Voltas, Varun Beverages, Chola Finance, UPL, Macrotech Developers, Max Healthcare, Kansai Nerolac and LIC Housing are among the companies that will announce their results for September 2022 quarter today.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Oct 27, 2022 1:16 PM
Stocks in the news: Hero Motocorp, Gland Pharma, SBI Cards, Dabur and DLF
Stocks in the news: Hero Motocorp, Gland Pharma, SBI Cards, Dabur and DLF
SBI Cards, Indus Towers, Tata Chemicals, REC, Aditya Birla Sun Life AMC, V-Guard Industries, Balaji Amines, Anupam Rasayan, TMB PNB Housing, Latent View and CE Infosystems is among the companies that will announce their results for September 2022 quarter today.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Oct 20, 2022 6:13 PM
Glenmark Pharma launches drug for diabetic patients with comorbidities
Glenmark Pharma launches drug for diabetic patients with comorbidities
The Mumbai-based drug maker said it has become the first company to launch Teneligliptin (20mg) + Dapagliflozin (5mg/10mg) fixed-dose combination for the treatment of adult patients with type 2 diabetes.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Oct 18, 2022 5:41 PM
50 smallcap stocks turnaround investors’ fortune multifold since last Samvat
50 smallcap stocks turnaround investors’ fortune multifold since last Samvat
PG Electroplast, Bharat Dynamics, Gujarat Fluorochemicals, Mazagon Dock Shipbuilders, Shoppers Stop, Speciality Restaurants, Deepak Fertilisers & Petrochemicals, Raymond, Shanthi Gears, Shree Renuka Sugars, DB Realty, Vadilal Industries, Mirza International, and Cressanda Solutions are among 50 smallcap stocks that have given more than 100% returns since last Diwali.
The Economic Times
Like
Comment
Share
Add a comment
RG finpati-display-image
Reputation: 3,728  •  Oct 18, 2022 5:20 AM


Glenmark Pharma : The stock that got crippled over a period. Gave buy calls previously on this. And just reiterating.

Gave actual buy call 320, but that was two years back.. and exited around 450. Now CMP is 394, buy more if 340 and 270 comes..

Targets a high 569,......read more
Chartbusters - chart - 14194231
2 Likes
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Oct 6, 2022 6:23 PM
Glenmark launches drug to treat patients with insulin-resistant diabetes
Glenmark launches drug to treat patients with insulin-resistant diabetes
The Mumbai-based drug firm has launched the medication under the brand name LOBG and is priced at around Rs 10 per tablet.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,687  •  Oct 6, 2022 4:13 PM
Glenmark Pharma launches drug for treatment of Type 2 diabetes in adults
Glenmark Pharma launches drug for treatment of Type 2 diabetes in adults
The launch of the drug is welcome news for diabetic patients with insulin resistance, which happens to be a common problem in India with every four out of ten diabetic patients showing insulin resistance in India.
Moneycontrol
Like
Comment
Share
Add a comment
Patil Investment-display-image
Reputation: 2,987  •  Oct 3, 2022 3:39 PM
Like
Comment
Share
Add a comment
Hangout traders-display-image
Reputation: 8,423  •  Oct 3, 2022 3:10 PM

#GLENMARK - hourly time frame
live chart update
careful with the resistance
Chartbusters - chart - 13354016
1 Like
Comment
Share
Add a comment
Call Put Analyst-display-image
Reputation: 19,634  •  Oct 1, 2022 5:19 AM

👌Super Bullish Call👌
---
1) Buy Glenmark 390 Call @ 15-18 (Near Range Only), Target 25/32/45/57+, Strict Stoploss 5
---
🌸Tips Date:- 03/10
🌸Hold Till:- 27/10 (Last Day Expiry)
🌸Safe Trader can book profit near 1st & 2nd target, high risk trader can hold till final target.
🌸......read more
1 Like
6 Comments
Share
Add a comment
Load More Posts